Pasireotide Pamoate Patent Expiration
Pasireotide Pamoate is Used for treating conditions related to excess growth hormone secretion, such as acromegaly. It was first introduced by Recordati Rare Diseases Inc
Pasireotide Pamoate Patents
Given below is the list of patents protecting Pasireotide Pamoate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Signifor Lar Kit | US9351923 | Extended-release composition comprising a somatostatin derivative in microparticles | May 23, 2028 | Recordati Rare |
| Signifor Lar Kit | US7473761 | Somatostatin analogues | Dec 14, 2026 | Recordati Rare |
| Signifor Lar Kit | US7759308 | Microparticles comprising somatostatin analogues | Oct 25, 2026 | Recordati Rare |
| Signifor Lar Kit | US8822637 | Somatostatin analogues |
Aug 06, 2023
(Expired) | Recordati Rare |
| Signifor Lar Kit | US6225284 | Somatostatin peptides |
Jun 28, 2016
(Expired) | Recordati Rare |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Pasireotide Pamoate's patents.
Latest Legal Activities on Pasireotide Pamoate's Patents
Given below is the list recent legal activities going on the following patents of Pasireotide Pamoate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Court Processing Terminated | 01 Mar, 2024 | US7473761 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 30 Nov, 2023 | US9351923 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 02 Mar, 2022 | US8822637 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 20 Jan, 2022 | US7759308 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 06 Jul, 2020 | US7473761 |
| Change in Power of Attorney (May Include Associate POA) Critical | 04 May, 2020 | US8822637 |
| Change in Power of Attorney (May Include Associate POA) Critical | 01 May, 2020 | US9351923 |
| Filing Receipt - Corrected | 01 May, 2020 | US9351923 |
| Correspondence Address Change Critical | 29 Apr, 2020 | US8822637 |
| Correspondence Address Change Critical | 28 Apr, 2020 | US9351923 |
Pasireotide Pamoate's Family Patents
